Skip to content

Our Portfolio

Lysomal Therapeutics

Lysosomal Therapeutics, is developing first-in-class therapies for neurological diseases with high unmet need. LTI is leveraging its world-class knowledge of lysosomal biology and drug development to deliver innovative agents for neurodegenerative disease.